Home › Targets › dopamine D3 receptor

dopamine D3 receptor (1 companies · 2 programs)

Companies with an active program directed at dopamine D3 receptor.

Alto Neuroscience, Inc. ANRO

  • ALTO-207 — Treatment Resistant Depression Phase 2
  • ALTO-208 — Parkinson's Disease Phase 2